Insmed (INSM) price target raised to $97.00 at Stifel
Tweet Send to a Friend
Stifel analyst Stephen D. Willey reiterated Insmed (NASDAQ: INSM) at Buy while raising the price target to $97.00 (from $88.00).The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
